UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 125

Sortiert nach

Impact and Effectiveness of the Quadrivalent Human Papillomavirus Vaccine: A Systematic Review of 10 Years of Real-world Experience

Clinical infectious diseases, 2016-08, Vol.63 (4), p.519-527

2016

Link zum Volltext

Verfügbarkeit prüfen

Association of plasma aflatoxin with persistent detection of oncogenic human papillomaviruses in cervical samples from Kenyan women enrolled in a longitudinal study

BMC infectious diseases, 2023-06, Vol.23 (1), p.377-377, Article 377

2023

Link zum Volltext

Verfügbarkeit prüfen

Vaccine-type human papillomavirus and evidence of herd protection after vaccine introduction

Pediatrics (Evanston), 2012-08, Vol.130 (2), p.e249

2012

Link zum Volltext

Verfügbarkeit prüfen

A Longitudinal Study of Genital Human Papillomavirus Infection in a Cohort of Closely Followed Adolescent Women

The Journal of infectious diseases, 2005-01, Vol.191 (2), p.182-192

2005

Link zum Volltext

Verfügbarkeit prüfen

A Controlled Trial of a Human Papillomavirus Type 16 Vaccine

The New England journal of medicine, 2002-11, Vol.347 (21), p.1645-1651

2002

Link zum Volltext

Verfügbarkeit prüfen

Clinical Trial and Post-Licensure Safety Profile of a Prophylactic Human Papillomavirus (Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine

The Pediatric infectious disease journal, 2010-02, Vol.29 (2), p.95-101

2010

Link zum Volltext

Verfügbarkeit prüfen

The Fanconi Anemia Pathway Limits Human Papillomavirus Replication

Journal of Virology, 2012-08, Vol.86 (15), p.8131-8138

2012

Link zum Volltext

Verfügbarkeit prüfen

Human papillomavirus seroprevalence and seroconversion following baseline detection of nine human papillomavirus types in young women

Tumour virus research, 2022-06, Vol.13, p.200236-200236, Article 200236

2022

Link zum Volltext

Verfügbarkeit prüfen

Human Papillomavirus Oral- and Sero- Positivity in Fanconi Anemia

Cancers, 2021-03, Vol.13 (6), p.1368

2021

Link zum Volltext

Verfügbarkeit prüfen

Potential of the quadrivalent human papillomavirus vaccine in the prevention and treatment of cervical cancer

Expert opinion on biological therapy, 2014-04, Vol.14 (4), p.527-534

2014

Link zum Volltext

Verfügbarkeit prüfen

High Frequency of Human Papillomavirus Detection in the Vagina Before First Vaginal Intercourse Among Females Enrolled in a Longitudinal Cohort Study

The Journal of infectious diseases, 2013-03, Vol.207 (6), p.1012-1015

2013

Link zum Volltext

Verfügbarkeit prüfen

The humoral response to Gardasil over four years as defined by Total IgG and competitive Luminex immunoassay

Human vaccines, 2011-02, Vol.7 (2), p.230-238

2011

Link zum Volltext

Verfügbarkeit prüfen

Human Papillomavirus Vaccine Effectiveness and Herd Protection in Young Women

Pediatrics (Evanston), 2019-02, Vol.143 (2)

2019

Link zum Volltext

Verfügbarkeit prüfen

Persistence of oncogenic and non-oncogenic human papillomavirus is associated with human immunodeficiency virus infection in Kenyan women

SAGE open medicine, 2020, Vol.8, p.2050312120945138-2050312120945138

2020

Link zum Volltext

Verfügbarkeit prüfen

Invasive cervical cancers in the United States, Botswana and Kenya: HPV type distribution and health policy implications

Infectious agents and cancer, 2016-11, Vol.11 (1), p.56-56, Article 56

2016

Link zum Volltext

Verfügbarkeit prüfen

Systematic literature review of cross-protective effect of HPV vaccines based on data from randomized clinical trials and real-world evidence

Vaccine, 2021-04, Vol.39 (16), p.2224-2236

2021

Link zum Volltext

Verfügbarkeit prüfen

Antibodies from Women Immunized with Gardasil ® Cross-Neutralize HPV 45 Pseudovirions

Human vaccines, 2007-07, Vol.3 (4), p.109-115

2007

Link zum Volltext

Verfügbarkeit prüfen

Substantial Decline in Vaccine-Type Human Papillomavirus (HPV) Among Vaccinated Young Women During the First 8 Years After HPV Vaccine Introduction in a Community

Clinical infectious diseases, 2016-11, Vol.63 (10), p.1281-1287

2016

Link zum Volltext

Verfügbarkeit prüfen

Systematic literature review of neutralizing antibody immune responses to non-vaccine targeted high-risk HPV types induced by the bivalent and the quadrivalent vaccines

Vaccine, 2021-04, Vol.39 (16), p.2214-2223

2021

Link zum Volltext

Verfügbarkeit prüfen

Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial

BMJ (British Medical Journal), 2010-07, Vol.341 (7766), p.c3493-239

International edition, 2010

Link zum Volltext

Verfügbarkeit prüfen

The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV-Naive Women Aged 16–26 Years

24th International Papillomavirus Conference and Clinical Workshop,2007-11-03 - 2007-11-09, 2009-04, Vol.199 (7), p.926-935

2009

Link zum Volltext

Verfügbarkeit prüfen

Longer duration of anti-retroviral therapy is associated with decreased risk of human papillomaviruses detection in Kenyan women living with HIV

International journal of STD & AIDS, 2021-11, Vol.32 (13), p.1212-1220

2021

Link zum Volltext

Verfügbarkeit prüfen

Human Papillomavirus in Older Women: New Infection or Reactivation?

The Journal of infectious diseases, 2013-01, Vol.207 (2), p.211-212

2013

Link zum Volltext

Verfügbarkeit prüfen

Episodic detection of human papillomavirus within a longitudinal cohort of young women

Journal of medical virology, 2015-12, Vol.87 (12), p.2122-2129

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 125

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(118)
Mit Volltextzugriff
(110)

Publikationsform

Artikel
(124)
Buchkapitel
(1)

Sprache

Englisch
(125)
Japanisch
(19)

Erscheinungsjahr

n.n

Thema

Science & Technology
(98)
Life Sciences & Biomedicine
(97)
Humans
(94)
Female
(69)
Human Papillomavirus
(50)
Biological And Medical Sciences
(47)
Adult
(46)
Virology
(45)
Adolescent
(43)
Infectious Diseases
(40)
Medical Sciences
(35)
Immunology
(33)
Microbiology
(33)
Papillomavirus Infections - Virology
(32)
Papillomaviridae - Genetics
(30)
Cervical Cancer
(25)
Papillomavirus Infections - Prevention & Control
(25)
Young Adult
(25)
Male
(24)
Papillomaviridae - Isolation & Purification
(24)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Impact and Effectiveness of the Quadrivalent Human Papillomavirus Vaccine: A Systematic Review of 10 Years of Real-world Experience

Association of plasma aflatoxin with persistent detection of oncogenic human papillomaviruses in cervical samples from Kenyan women enrolled in a longitudinal study

Vaccine-type human papillomavirus and evidence of herd protection after vaccine introduction

A Longitudinal Study of Genital Human Papillomavirus Infection in a Cohort of Closely Followed Adolescent Women

A Controlled Trial of a Human Papillomavirus Type 16 Vaccine

Clinical Trial and Post-Licensure Safety Profile of a Prophylactic Human Papillomavirus (Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine

The Fanconi Anemia Pathway Limits Human Papillomavirus Replication

Human papillomavirus seroprevalence and seroconversion following baseline detection of nine human papillomavirus types in young women

Human Papillomavirus Oral- and Sero- Positivity in Fanconi Anemia

Potential of the quadrivalent human papillomavirus vaccine in the prevention and treatment of cervical cancer

High Frequency of Human Papillomavirus Detection in the Vagina Before First Vaginal Intercourse Among Females Enrolled in a Longitudinal Cohort Study

The humoral response to Gardasil over four years as defined by Total IgG and competitive Luminex immunoassay

Human Papillomavirus Vaccine Effectiveness and Herd Protection in Young Women

Persistence of oncogenic and non-oncogenic human papillomavirus is associated with human immunodeficiency virus infection in Kenyan women

Invasive cervical cancers in the United States, Botswana and Kenya: HPV type distribution and health policy implications

Systematic literature review of cross-protective effect of HPV vaccines based on data from randomized clinical trials and real-world evidence

Antibodies from Women Immunized with Gardasil ® Cross-Neutralize HPV 45 Pseudovirions

Substantial Decline in Vaccine-Type Human Papillomavirus (HPV) Among Vaccinated Young Women During the First 8 Years After HPV Vaccine Introduction in a Community

Systematic literature review of neutralizing antibody immune responses to non-vaccine targeted high-risk HPV types induced by the bivalent and the quadrivalent vaccines

Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial

The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV-Naive Women Aged 16–26 Years

Longer duration of anti-retroviral therapy is associated with decreased risk of human papillomaviruses detection in Kenyan women living with HIV

Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial

Human Papillomavirus in Older Women: New Infection or Reactivation?

Episodic detection of human papillomavirus within a longitudinal cohort of young women

Suchergebnisse filtern